tiprankstipranks
Advertisement
Advertisement

INBX Stock Latest News

Inhibrx reports Q4 EPS ($2.11) vs. ($3.09) last year
The FlyInhibrx reports Q4 EPS ($2.11) vs. ($3.09) last year
15d ago
INBX
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy
PremiumCompany Announcements
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy
1M ago
8K
INBX
PremiumCompany Announcements
Inhibrx Biosciences Updates on Clinical Trials Progress
4M ago
8K
INBX
Inhibrx provides update on INBRX-106 Phase 2/3 clinical trial
PremiumThe Fly
Inhibrx provides update on INBRX-106 Phase 2/3 clinical trial
4M ago
INBX
PremiumCompany Announcements
Inhibrx Biosciences Reports Promising Q3 2025 Results
4M ago
INBX
Inhibrx options imply 7.3% move in share price post-earnings
PremiumThe FlyInhibrx options imply 7.3% move in share price post-earnings
5M ago
INBX
Premium
Pre-Earnings
Is INBX a Buy, Before Earnings?
5M ago
INBX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
FIG
TBT
PremiumCompany Announcements
Inhibrx’s Promising Study on INBRX-106 for Advanced Head and Neck Cancer
5M ago
INBX
PremiumCompany Announcements
Inhibrx Biosciences Advances Cancer Treatment with INBRX-106 Study Update
5M ago
INBX
PremiumCompany Announcements
Inhibrx’s Phase 2 Study on INBRX-109: A Potential Breakthrough in Chondrosarcoma Treatment
5M ago
INBX
PremiumCompany Announcements
Inhibrx’s Phase 1 Study of INBRX-109: A Potential Game-Changer in Cancer Treatment
5M ago
INBX
Midday Fly By: Intel, Ford report Q3 beats
PremiumThe FlyMidday Fly By: Intel, Ford report Q3 beats
5M ago
F
BX
Why Is Inhibrx Biosciences Stock (INBX) Surging Today?
Premium
Market News
Why Is Inhibrx Biosciences Stock (INBX) Surging Today?
5M ago
INBX
Inhibrx trading resumes
Premium
The Fly
Inhibrx trading resumes
5M ago
INBX
PremiumCompany Announcements
Inhibrx Biosciences Reports Positive ChonDRAgon Study Results
5M ago
8K
INBX
Inhibrx reports positive topline results from registrational trial of ozekibart
PremiumThe Fly
Inhibrx reports positive topline results from registrational trial of ozekibart
5M ago
INBX
Inhibrx trading halted, news pending
PremiumThe Fly
Inhibrx trading halted, news pending
5M ago
INBX
PremiumCompany Announcements
Inhibrx Biosciences Reports Q2 2025 Financial Results
7M ago
INBX
Inhibrx reports Q2 EPS ($1.85) vs. $125.48 last year
PremiumThe FlyInhibrx reports Q2 EPS ($1.85) vs. $125.48 last year
8M ago
INBX
Premium
Company Announcements
Inhibrx’s Promising Study on INBRX-106 for Head and Neck Cancer
9M ago
INBX
Premium
Company Announcements
Inhibrx Biosciences Concludes 2025 Annual Stockholders Meeting
10M ago
8K
INBX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >